Evaluate: Webinar

For ten years, orphan drugs have doubled their market share in global prescription drug sales, surpassing non-orphan drugs. However, their once bright gloss is beginning to dull, and their growth advantage is diminishing. 

Sign up for our webinar to discover the reasons behind this shift and what the future may hold.

Get expert insights on:

Major players in the field
Exciting therapy areas
Technologies primed to drive growth
Rare diseases' significance for big pharma
What's piquing investors' interest?
The impact of new legislation on R&D pipelines

Your Hosts:

Melanie Senior,
Author, Orphan Drug Report

Stephanie Léouzon,

Managing Director, Biopharma Healthcare,

Stifel

Puru Gaur,
Senior Commercial Analyst, Evaluate

Please complete the form to book your place.

Email Address*

First Name*

Last Name*

Job Title*

Company*

Country*

Area of Business*

Ask a Question for the panel

I would like to receive Evaluate industry & market reports, and the latest news from Evaluate.